Perrigo (NYSE: PRGO) has recently received a number of price target changes and ratings updates:

  • 1/4/2019 – Perrigo was given a new $50.00 price target on by analysts at Royal Bank of Canada. They now have a “hold” rating on the stock.
  • 12/30/2018 – Perrigo was given a new $46.00 price target on by analysts at Wells Fargo & Co. They now have a “hold” rating on the stock.
  • 12/30/2018 – Perrigo was given a new $67.00 price target on by analysts at Morgan Stanley. They now have a “hold” rating on the stock.
  • 12/24/2018 – Perrigo had its price target lowered by analysts at Leerink Swann from $70.00 to $56.00.
  • 12/23/2018 – Perrigo was given a new $67.00 price target on by analysts at Morgan Stanley. They now have a “hold” rating on the stock.
  • 12/21/2018 – Perrigo had its price target lowered by analysts at Wells Fargo & Co from $64.00 to $46.00. They now have a “market perform” rating on the stock.
  • 12/20/2018 – Perrigo was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating.
  • 12/20/2018 – Perrigo was given a new $107.00 price target on by analysts at Cantor Fitzgerald. They now have a “buy prgo” rating on the stock.
  • 12/5/2018 – Perrigo was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating.
  • 11/16/2018 – Perrigo was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating.

PRGO opened at $45.34 on Monday. Perrigo Company PLC has a 12-month low of $36.28 and a 12-month high of $95.93. The company has a current ratio of 1.85, a quick ratio of 1.26 and a debt-to-equity ratio of 0.54. The stock has a market cap of $6.00 billion, a P/E ratio of 9.20, a PEG ratio of 1.61 and a beta of 1.10.

Perrigo (NYSE:PRGO) last posted its earnings results on Thursday, November 8th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. Perrigo’s revenue was down 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.39 EPS. Equities analysts forecast that Perrigo Company PLC will post 4.55 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 18th. Shareholders of record on Friday, November 30th were given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date of this dividend was Thursday, November 29th. Perrigo’s dividend payout ratio is currently 15.42%.

In other Perrigo news, Director Geoffrey M. Parker bought 3,000 shares of the business’s stock in a transaction dated Monday, November 12th. The shares were acquired at an average price of $65.35 per share, with a total value of $196,050.00. Following the transaction, the director now owns 3,229 shares of the company’s stock, valued at $211,015.15. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Todd W. Kingma bought 3,200 shares of the business’s stock in a transaction dated Friday, November 9th. The shares were acquired at an average cost of $63.99 per share, for a total transaction of $204,768.00. Following the transaction, the vice president now directly owns 23,587 shares in the company, valued at approximately $1,509,332.13. The disclosure for this purchase can be found here. Insiders acquired a total of 25,783 shares of company stock worth $1,646,976 in the last ninety days. 6.90% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the company. Tower Research Capital LLC TRC grew its stake in Perrigo by 35.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,590 shares of the company’s stock worth $262,000 after buying an additional 930 shares during the last quarter. Penserra Capital Management LLC grew its stake in Perrigo by 16.5% during the 3rd quarter. Penserra Capital Management LLC now owns 6,900 shares of the company’s stock worth $488,000 after buying an additional 975 shares during the last quarter. Cullen Frost Bankers Inc. grew its stake in Perrigo by 1.2% during the 3rd quarter. Cullen Frost Bankers Inc. now owns 92,064 shares of the company’s stock worth $6,518,000 after buying an additional 1,048 shares during the last quarter. Andra AP fonden grew its stake in Perrigo by 1.4% during the 2nd quarter. Andra AP fonden now owns 91,400 shares of the company’s stock worth $6,664,000 after buying an additional 1,300 shares during the last quarter. Finally, Stone Ridge Asset Management LLC grew its stake in Perrigo by 11.3% during the 3rd quarter. Stone Ridge Asset Management LLC now owns 14,746 shares of the company’s stock worth $1,044,000 after buying an additional 1,500 shares during the last quarter. 87.48% of the stock is currently owned by institutional investors and hedge funds.

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Featured Story: The risks of owning bonds

Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with MarketBeat.com's FREE daily email newsletter.